NGR6538: Psychopharmacology 3

Co-requisite: NGR 6894, NGR 6740, and MHS 6430
Description: This course will focus on current evidence-based pharmacological treatments for psychiatric diagnoses across the lifespan. Current molecular, developmental and environmental perspectives are examined, including inherited and acquired vulnerabilities to mental illness. An in-depth review of neurological anatomy and receptors is presented. Emphasis is placed on the responsibilities of the PMHNP in the psychopharmacologic treatment of all mental health diagnoses that focuses on optimal outcomes.
Availability: One semester per year